The emerging therapeutic landscape of relapsed/refractory multiple myeloma
Benjamin Tanenbaum, Timothy Miett, Shyam A. Patel
Topics & Concepts
MedicineClinical trialTolerabilityMultiple myelomaOncologyPopulationLenalidomideCarfilzomibInternal medicineAdverse effectEnvironmental healthMultiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsCAR-T cell therapy research